Show
Sort by
-
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study
-
- Journal Article
- A1
- open access
Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis
-
Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis
-
Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis
-
Local and systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis
-
Non-pathogenic antinuclear antibodies contribute to the clearance of apoptotic antigens released during TNF alpha blockade in spondyloarthritis (SpA)
-
Anti-TNFalpha induced apoptosis contributes to the induction of autoantibodies but not the decrease of synovial inflammation in spondyloarthropathy (SpA)
-
Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint
-
Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis
-
Anti-TNFalpha induced apoptosis contributes to the induction of autoantibodies but not the decrease of synovial inflammation in spondyloarthropathy
-
Anti-TNF alpha induced apoptosis contributes to the induction of Autoantibodies but not the decrease of synovial inflammation in spondyloarthropathy (SPA)
-
Growth promoting effect of human cartilage glycoprotein-39 (HC gp-39) on synovial fibroblasts
-
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis
-
Identification of synovial biomarkers of response to treatment in spondyloarthropathy
-
Growth promoting effect of human cartilage glycoprotein-39 (HC gp-39)on synovial fibroblasts
-
Local production of the cartilage protein melanoma inhibitory activity (MIA) in the inflamed joint: Disease specificity, regulation by IL-1, and association with radiological joint damage
-
Impact of natural changes in disease activity on synovial histopathology in rheumatoid arthritis
-
Tumor necrosis factor a blockade treatment down-modulates the increased systemic and local expression of toll-like receptor 2 and toll-like receptor 4 in spondylarthropathy
-
- Journal Article
- A1
- open access
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis
-
Juvenile chronic arthritis displays synovial features distinct from both spondyloarthropathy and rheumatoid arthritis
-
Human cartilage glycoprotein-39 (HC gp-39) as growth factor for synovial fibroblasts
-
The cartilage protein Melanoma Inhibitory Activity (MIA) is produced locally in the arthritic joint but does not correlate with radiological joint damage
-
Increased systemic and local expression of toll-like receptor 2 and 4 in spondyloarthropathy is downmodulated by tumour necrosis factor alpha blockade
-
Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology - A prospective study in 154 consecutive patients
-
Effect of infliximab treatment on T cell cytokine responses in spondylarthropathy: comment on the article by Zou et al
-
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy
-
Effect of infliximab on matrix metalloprotelinase (MMP)-1,-2,-3 and tissue inhibitors of matrix metalloproteinases (TIMP)-1,-2 in spondyloarthropathy (SpA) synovitis
-
The diagnostic value of synovial histopathology in undifferentiated inflammatory arthritis: a prospective study in 154 consecutive patients